OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Evaluation of Senescence and Its Prevention in Doxorubicin-Induced Cardiotoxicity Using Dynamic Engineered Heart Tissues
Annet N. Linders, Itamar Braga Dias, Ekaterina S. Ovchinnikova, et al.
JACC CardioOncology (2023) Vol. 5, Iss. 3, pp. 298-315
Open Access | Times Cited: 16

Showing 16 citing articles:

A review of the pathophysiological mechanisms of doxorubicin-induced cardiotoxicity and aging
Annet N. Linders, Itamar Braga Dias, Teresa López‐Fernández, et al.
npj Aging (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 53

Priorities in Cardio-Oncology Basic and Translational Science
Fadi N. Salloum, Carlo G. Tocchetti, Pietro Ameri, et al.
JACC CardioOncology (2023) Vol. 5, Iss. 6, pp. 715-731
Open Access | Times Cited: 23

Cardiomyocyte senescence and the potential therapeutic role of senolytics in the heart
Peiyong Zhai, Junichi Sadoshima
The Journal of Cardiovascular Aging (2024) Vol. 4, Iss. 2
Open Access | Times Cited: 9

FNDC5/irisin mitigates the cardiotoxic impacts of cancer chemotherapeutics by modulating ROS-dependent and -independent mechanisms
Manish Kumar, Abhishek Singh Sengar, Anushree Lye, et al.
Redox Biology (2025) Vol. 80, pp. 103527-103527
Open Access | Times Cited: 1

Sex-related differences in delayed doxorubicin-induced cardiac dysfunction in C57BL/6 mice
Ibrahim Y. Abdelgawad, Benu George, Marianne Grant, et al.
Archives of Toxicology (2024) Vol. 98, Iss. 4, pp. 1191-1208
Closed Access | Times Cited: 4

Doxorubicin-Induced Cardiac Remodeling: Mechanisms and Mitigation Strategies
Yingpu Sun, Lili Xiao, Linlin Chen, et al.
Cardiovascular Drugs and Therapy (2025)
Closed Access

Anthracycline-induced cardiotoxicity: emerging mechanisms and therapies
Guanjing Ling, Fei Ge, Weili Li, et al.
Medicine Plus (2025), pp. 100074-100074
Open Access

Unveiling the role of tyrosine kinases in doxorubicin-induced cardiotoxicity and beyond
Edoardo Lazzarini, Claudia Altomare, Lucio Barile
Cardiovascular Research (2025)
Closed Access

Anticancer drugs and cardiotoxicity: the role of cardiomyocyte and non-cardiomyocyte cells
Chrysa Koukorava, Katie Ahmed, Shrouq Almaghrabi, et al.
Frontiers in Cardiovascular Medicine (2024) Vol. 11
Open Access | Times Cited: 3

Therapy-induced senescence is finally escapable, what is next?
Tareq Saleh
Cell Cycle (2024) Vol. 23, Iss. 6, pp. 713-721
Closed Access | Times Cited: 2

Identification of Prominin‐2 as a new player of cardiomyocyte senescence in the aging heart
Damien Maggiorani, Yohan Santin, Karina Formoso, et al.
Aging Cell (2024) Vol. 23, Iss. 9
Open Access | Times Cited: 1

Premature Cardiac Senescence
Giselle C. Meléndez, Nazli Gharraee, David A. Gewirtz
JACC CardioOncology (2023) Vol. 5, Iss. 3, pp. 316-317
Open Access | Times Cited: 2

Anthracycline-induced cardiotoxicity – primary preventive options. An overview
S Slavcheva
Bulgarian Cardiology (2024) Vol. 30, Iss. 1, pp. 20-40
Open Access

The role of senescence in cancer therapy-associated cardiovascular toxicity
Yasmin K. Alshoubaki, Vivienne Grüterich, Valentina Zollet, et al.
The Journal of Cardiovascular Aging (2024) Vol. 4, Iss. 4
Open Access

Diagnostic and Therapeutic Approaches for Heart Failure in Long-Term Survivors of Childhood Cancer
Consuelo Fernández‐Avilés, Rafael González Manzanares, Soledad Ojeda, et al.
Biomedicines (2024) Vol. 12, Iss. 8, pp. 1875-1875
Open Access

Page 1

Scroll to top